In 2023, the trade exchange (includes international purchases and sales) of Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) was US$139M.
In 2023, the states with the most international sales in Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) were Estado de México (US$9.22M) and Ciudad de México (US$1.11k).
The states with the most international purchases in 2023 were Jalisco (US$66.9M), Ciudad de México (US$34.2M), Estado de México (US$19.4M), and Querétaro (US$556k).
In 2023, the main commercial destinations of Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) were Spain (US$3.65M), Turkey (US$1.35M), Russia (US$702k), Brazil (US$609k), and Switzerland (US$574k).
The main commercial origins of Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) in 2023 were China (US$68.4M), India (US$17.7M), Spain (US$16.4M), Ireland (US$4.05M), and Singapore (US$2.63M).
In the global context, the main exporting countries of Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) in 2022 were China (US$2.53B), Switzerland (US$762M), and Italy (US$691M). In the same year, the main importing countries of Antibiotics (Exc Penicillins, their Derivatives with a Penicillanic Acid Structure, and Salts Thereof;. Streptomycins, Tetracyclines, Chloramphenicol and Erythromycin, Salts and Derivatives Thereof) were Italy (US$791M), India (US$768M), and Germany (US$615M).